Naloxone injected into the preoptic region has hypophysiotropic and seizurogenic actions in rats.
The effects of microinjection of naloxone, an opiate receptor antagonist, into the medial preoptic area (MPO) and diagonal band of Broca (DBB) on luteinizing hormone (LH) and prolactin (PRL) secretion were examined in the intact male rat and female rat in diestrus 1. In both the male and female rats, the injection of 50 micrograms naloxone at 1300 h produced an acute, two- to three-fold increase in serum LH, attaining the peak at 20 min. The PRL concentration in the female 20 min-2 h after the injection was significantly lower than in the saline-injected rat. In the male rat, naloxone caused a decrease in the PRL concentration in the late afternoon when a small rise occurred in the saline-injected rat, although it caused no immediate changes. In addition to these hypophysiotropic effects, naloxone injected in the MPO and DBB unexpectedly had seizurogenic actions. More than 40% of the animals of both sexes given an injection of naloxone had behavioral seizures, which began after about 20 min and were repeated intermittently at 15-20 min intervals through the sampling period of 6 h. In the LH and PRL response to naloxone, there was no significant difference between animals with and without seizure response in both sexes. The results suggest that in the preoptic opioid system there is no difference according to sex in the control of LH, and only a small one, if any, in the control of PRL. Further, on the basis of previous reports, there is a GABAergic system in the preoptic region, that is antagonized by naloxone and causes the activation of cortical neuronal activity.
Hashimoto
R
R
Department of Physiology, Yokohama City University, Japan.
Sano
A
A
Nishimura
J
J
Funabashi
T
T
Kimura
F
F
D000818:Animals; D004031:Diestrus / Q000502:physiology; D004569:Electroencephalography / Q000187:drug effects; D005260:Female; D005625:Frontal Lobe / Q000187:drug effects*; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism; D008297:Male; D009270:Naloxone / Q000633:toxicity*; D011301:Preoptic Area / Q000187:drug effects*; D011388:Prolactin / Q000097:blood / Q000378:metabolism; D011863:Radioimmunoassay; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000139:chemically induced*; D012727:Sex Characteristics; D013737:Testis / Q000502:physiology
D009270:Naloxone; D011388:Prolactin; D007986:Luteinizing Hormone